Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Avacopan may cause unexpected side effects, so early monitoring is important.

A woman with severe angioedema improved significantly after treatment with rituximab.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Pexidartinib often causes liver issues and fatigue, especially in women.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Resveratrol shows health benefits but faces challenges in effectiveness and regulation.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Ruxolitinib can help regrow hair in severe alopecia areata.

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Topical Ruxolitinib may safely treat severe hair loss.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.